These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16859401)

  • 1. Drug-drug interactions involving membrane transporters in the human kidney.
    Li M; Anderson GD; Wang J
    Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):505-32. PubMed ID: 16859401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporters and drug-drug interactions: important determinants of drug disposition and effects.
    König J; Müller F; Fromm MF
    Pharmacol Rev; 2013 Jul; 65(3):944-66. PubMed ID: 23686349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Drug Transporters in Pharmacotherapy.
    Łapczuk-Romańska J; Droździk M; Oswald S; Droździk M
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transporter-mediated drug interaction].
    Komori H; Tamai I
    Nihon Yakurigaku Zasshi; 2014 May; 143(5):243-8. PubMed ID: 24813795
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.
    Chu X; Chan GH; Evers R
    J Pharm Sci; 2017 Sep; 106(9):2357-2367. PubMed ID: 28416420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of Renal Drug Transporter in Drug Disposition and Renal Toxicity.
    Yang X; Han L
    Adv Exp Med Biol; 2019; 1141():341-360. PubMed ID: 31571169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters in drug development and clinical pharmacology.
    Giacomini KM; Huang SM
    Clin Pharmacol Ther; 2013 Jul; 94(1):3-9. PubMed ID: 23778703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative prediction of renal transporter-mediated clinical drug-drug interactions.
    Feng B; Hurst S; Lu Y; Varma MV; Rotter CJ; El-Kattan A; Lockwood P; Corrigan B
    Mol Pharm; 2013 Nov; 10(11):4207-15. PubMed ID: 24066726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transporters involved in the elimination of drugs in the kidney: organic anion transporters and organic cation transporters.
    Dresser MJ; Leabman MK; Giacomini KM
    J Pharm Sci; 2001 Apr; 90(4):397-421. PubMed ID: 11170032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporters and renal drug elimination.
    Lee W; Kim RB
    Annu Rev Pharmacol Toxicol; 2004; 44():137-66. PubMed ID: 14744242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examination of the emerging role of transporters in the assessment of nephrotoxicity.
    Chen Y; Lu S; Zhang Y; Chen B; Zhou H; Jiang H
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):787-804. PubMed ID: 36420583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intestinal absorption and renal excretion mediated by transporters and the relationship with drug-drug interaction].
    Zhang J; Liu KX
    Yao Xue Xue Bao; 2010 Sep; 45(9):1089-94. PubMed ID: 21351563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant?
    Lepist EI; Ray AS
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S73-81. PubMed ID: 27385181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of transporters in drug interactions.
    Endres CJ; Hsiao P; Chung FS; Unadkat JD
    Eur J Pharm Sci; 2006 Apr; 27(5):501-17. PubMed ID: 16364611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple human isoforms of drug transporters contribute to the hepatic and renal transport of olmesartan, a selective antagonist of the angiotensin II AT1-receptor.
    Yamada A; Maeda K; Kamiyama E; Sugiyama D; Kondo T; Shiroyanagi Y; Nakazawa H; Okano T; Adachi M; Schuetz JD; Adachi Y; Hu Z; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2007 Dec; 35(12):2166-76. PubMed ID: 17823233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The altered renal and hepatic expression of solute carrier transporters (SLCs) in type 1 diabetic mice.
    Xu C; Zhu L; Chan T; Lu X; Shen W; Gillies MC; Zhou F
    PLoS One; 2015; 10(3):e0120760. PubMed ID: 25789863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.